The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19

Gorolyuk Anna Yuriyivna

doi:doi:10.11648/j.cmr.20211005.13

| Peer-Reviewed

The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19

Gorolyuk Anna Yuriyivna

Published in Clinical Medicine Research (Volume 10, Issue 5)

Received: 3 October 2021 Accepted: 21 October 2021 Published: 30 October 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Since the announcement of the COVID-19 pandemic (March 11, 2020), the focus of the study of complications of this new coronavirus disease has been on pneumonia and acute respiratory distress syndrome. Meanwhile, with COVID-19, acute abdominal surgical diseases develop, presumably due to the tropism of the COVID-19 virus to angiotensin-converting enzyme receptors in the digestive tract. In principle, previously known coronaviruses could cause infectious peritonitis, however, such cases of coronavirus peritonitis were observed exclusively in animals. In particular, FIPV - coronavirus is the direct cause of feline infectious peritonitis. This article describes a rare, alarming case of serous fibrinous peritonitis as a casuistic manifestation of a new coronavirus infection COVID-19 directly in humans: a 55-year-old female patient. Surgical diseases that could cause the development of this peritonitis in this patient were excluded. The purpose of the article is to point out the possibility of the development of this surgical disease, as a direct complication of the new coronavirus infection COVID-19. The article also presents the author's attempt to explain in general terms the pathogenesis of the development of peritonitis in COVID-19 in humans. Observing the second year of the pandemic, extremely rare mentions in medical scientific articles of cases of primary peritonitis in COVID-19, we can conclude that this complication is not typical in this new infection. However, given the too short period since the emergence of a new coronavirus infection COVID-19 (less than two years), as well as the ability of a new strain of coronavirus to mutate, we can assume that, in principle, the possibility of developing coronavirus peritonitis in humans is not excluded in the future.

Published in	Clinical Medicine Research (Volume 10, Issue 5)
DOI	10.11648/j.cmr.20211005.13
Page(s)	169-172
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Coronavirus Disease SARS-CoV-2 COVID-19, Peritonitis, Serous Fibrinous Peritonitis

References

[1]	Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506. https://doi.org/10.1016/s0140-6736(20)30183-5
[2]	R. Blanco-Colino, R. Vilallonga, R. Martin, et al. Suspected acute abdomen as an extrapulmonary manifestation of COVID-19 infection/ Gir Esp, 98 (May (5)) (2020), pp. 295-296.
[3]	A. O. E. Ahmed, M. Badawi, K. Ahmed, et al. Case report: COVID-19 masquerading as an acute surgical abdomen (2020). June 9; tpmd200559.
[4]	Paula H. Takegawa, Marcia Calavaro Silva, Caroline Belluco, et al. “Inflammatory peritonitis in a child with COVID-19”, Jornal of Pediatric Surgery Case Reports, Decenber 2021, 102077\| https://doi.org/10.1016/j.epsc.2021.102077
[5]	Ashraf Omer Elamin Ahmed, Sars F. Mohamed, Ahmed O. Saleh et al. Acute abdomen-like-presentation assotiated with SARS-CoV-2 infektion, IDCases 2020, e00895, ScienceDirekt\| https//doi.org/10.1016/j.idcr.2020.e00895
[6]	Al Argan, Safi G Algatari, Abir H Al Said et al. Gastrointestinal perforation secondary to COVID-19: case reports and literature review. Medicine (Baltimore). 2021 May 14; 100 (19): e25771/ doi: 10.1097/MD.0000000000025771.
[7]	Dragos Serban, Bogdan Socea, Cristinel Dumitru Badiu, et al. Acute surgical abdomen during the COVID-19 pandemie: Clinical and therapeutic challenges, Experimental and Therapeutic Medicine, March 22, 2021\| https://doi.org/10.3892/etm.2021.9950
[8]	Islam H. Elrobaa and Karl I. New. COVID-19: Pulmonary Manifestations, Frontiers in Public Health, 28 september 2021\| httrs://doi.org/10.3389/fpubh,2021.711616
[9]	Di Saverio S., Khan M., Pata F., Ietto G., De Simone B., Zani E. Laparoscopy at all costs? Not now during COVID-19 and not for acute care surgery and emergency colorectal surgery: a practical algorithm from a Hub Tertiary teaching hospital in Northern Lombardy, Italy. J Trauma Acute Care Surg. 2020; 88 (6): 715–718. doi: 10.1097/TA.0000000000002727.
[10]	De Simone B., Chouillard E., Di Saverio S., Pagani L., Sartelli M., Biffl W. L., Campanile F. C. Emergency surgery during the COVID-19 pandemic: what you need to know for practice. Ann R Coll Surg Engl. 2020: 1–10. 0.
[11]	Zheng M. H., Boni L., Fingerhut A. Minimally invasive surgery and the novel coronavirus outbreak: lessons learned in China and Italy. Ann Surg. 2020; 272 (1): e5–e6. doi: 10.1097/SLA.0000000000003924.
[12]	Wang Juan, Du Guoqiang. COVID-19 may transmit through aerosol. Ir J Med Sci. 2020: 1–2.
[13]	Champault G., Taffinder N., Ziol M., Riskalla H., Catheline J. M. C. Cells are present in the smoke created during laparoscopic surgery. Br J Surg. 1997; 84 (7): 993–995.
[14]	Al-Balas M., Al-Balas H. I., Al-Balas H. Surgery during the COVID-19 pandemic: a comprehensive overview and perioperative care. Am J Surg. 2020 April 18 doi: 10.1016/j.amjsurg.2020.04018.
[15]	Francis N., Dort J., Cho E., Feldman L., Keller D., Lim R., Wasco K. SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic. Surg Endosc. 2020: 1–5.

Cite This Article

Plain Text BibTeX RIS

APA Style

Gorolyuk Anna Yuriyivna. (2021). The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19. Clinical Medicine Research, 10(5), 169-172. https://doi.org/10.11648/j.cmr.20211005.13

Copy | Download

ACS Style

Gorolyuk Anna Yuriyivna. The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19. Clin. Med. Res. 2021, 10(5), 169-172. doi: 10.11648/j.cmr.20211005.13

Copy | Download

AMA Style

Gorolyuk Anna Yuriyivna. The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19. Clin Med Res. 2021;10(5):169-172. doi: 10.11648/j.cmr.20211005.13

Copy | Download

@article{10.11648/j.cmr.20211005.13,
  author = {Gorolyuk Anna Yuriyivna},
  title = {The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19},
  journal = {Clinical Medicine Research},
  volume = {10},
  number = {5},
  pages = {169-172},
  doi = {10.11648/j.cmr.20211005.13},
  url = {https://doi.org/10.11648/j.cmr.20211005.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20211005.13},
  abstract = {Since the announcement of the COVID-19 pandemic (March 11, 2020), the focus of the study of complications of this new coronavirus disease has been on pneumonia and acute respiratory distress syndrome. Meanwhile, with COVID-19, acute abdominal surgical diseases develop, presumably due to the tropism of the COVID-19 virus to angiotensin-converting enzyme receptors in the digestive tract. In principle, previously known coronaviruses could cause infectious peritonitis, however, such cases of coronavirus peritonitis were observed exclusively in animals. In particular, FIPV - coronavirus is the direct cause of feline infectious peritonitis. This article describes a rare, alarming case of serous fibrinous peritonitis as a casuistic manifestation of a new coronavirus infection COVID-19 directly in humans: a 55-year-old female patient. Surgical diseases that could cause the development of this peritonitis in this patient were excluded. The purpose of the article is to point out the possibility of the development of this surgical disease, as a direct complication of the new coronavirus infection COVID-19. The article also presents the author's attempt to explain in general terms the pathogenesis of the development of peritonitis in COVID-19 in humans. Observing the second year of the pandemic, extremely rare mentions in medical scientific articles of cases of primary peritonitis in COVID-19, we can conclude that this complication is not typical in this new infection. However, given the too short period since the emergence of a new coronavirus infection COVID-19 (less than two years), as well as the ability of a new strain of coronavirus to mutate, we can assume that, in principle, the possibility of developing coronavirus peritonitis in humans is not excluded in the future.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19
AU  - Gorolyuk Anna Yuriyivna
Y1  - 2021/10/30
PY  - 2021
N1  - https://doi.org/10.11648/j.cmr.20211005.13
DO  - 10.11648/j.cmr.20211005.13
T2  - Clinical Medicine Research
JF  - Clinical Medicine Research
JO  - Clinical Medicine Research
SP  - 169
EP  - 172
PB  - Science Publishing Group
SN  - 2326-9057
UR  - https://doi.org/10.11648/j.cmr.20211005.13
AB  - Since the announcement of the COVID-19 pandemic (March 11, 2020), the focus of the study of complications of this new coronavirus disease has been on pneumonia and acute respiratory distress syndrome. Meanwhile, with COVID-19, acute abdominal surgical diseases develop, presumably due to the tropism of the COVID-19 virus to angiotensin-converting enzyme receptors in the digestive tract. In principle, previously known coronaviruses could cause infectious peritonitis, however, such cases of coronavirus peritonitis were observed exclusively in animals. In particular, FIPV - coronavirus is the direct cause of feline infectious peritonitis. This article describes a rare, alarming case of serous fibrinous peritonitis as a casuistic manifestation of a new coronavirus infection COVID-19 directly in humans: a 55-year-old female patient. Surgical diseases that could cause the development of this peritonitis in this patient were excluded. The purpose of the article is to point out the possibility of the development of this surgical disease, as a direct complication of the new coronavirus infection COVID-19. The article also presents the author's attempt to explain in general terms the pathogenesis of the development of peritonitis in COVID-19 in humans. Observing the second year of the pandemic, extremely rare mentions in medical scientific articles of cases of primary peritonitis in COVID-19, we can conclude that this complication is not typical in this new infection. However, given the too short period since the emergence of a new coronavirus infection COVID-19 (less than two years), as well as the ability of a new strain of coronavirus to mutate, we can assume that, in principle, the possibility of developing coronavirus peritonitis in humans is not excluded in the future.
VL  - 10
IS  - 5
ER  -

Copy | Download

Author Information

Gorolyuk Anna Yuriyivna

Department of Surgery, Hospital № 7, Kriviy Rih, Ukraine

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Gorolyuk Anna Yuriyivna. (2021). The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19. Clinical Medicine Research, 10(5), 169-172. https://doi.org/10.11648/j.cmr.20211005.13

Copy | Download

ACS Style

Gorolyuk Anna Yuriyivna. The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19. Clin. Med. Res. 2021, 10(5), 169-172. doi: 10.11648/j.cmr.20211005.13

Copy | Download

AMA Style

Gorolyuk Anna Yuriyivna. The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19. Clin Med Res. 2021;10(5):169-172. doi: 10.11648/j.cmr.20211005.13

Copy | Download

@article{10.11648/j.cmr.20211005.13,
  author = {Gorolyuk Anna Yuriyivna},
  title = {The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19},
  journal = {Clinical Medicine Research},
  volume = {10},
  number = {5},
  pages = {169-172},
  doi = {10.11648/j.cmr.20211005.13},
  url = {https://doi.org/10.11648/j.cmr.20211005.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20211005.13},
  abstract = {Since the announcement of the COVID-19 pandemic (March 11, 2020), the focus of the study of complications of this new coronavirus disease has been on pneumonia and acute respiratory distress syndrome. Meanwhile, with COVID-19, acute abdominal surgical diseases develop, presumably due to the tropism of the COVID-19 virus to angiotensin-converting enzyme receptors in the digestive tract. In principle, previously known coronaviruses could cause infectious peritonitis, however, such cases of coronavirus peritonitis were observed exclusively in animals. In particular, FIPV - coronavirus is the direct cause of feline infectious peritonitis. This article describes a rare, alarming case of serous fibrinous peritonitis as a casuistic manifestation of a new coronavirus infection COVID-19 directly in humans: a 55-year-old female patient. Surgical diseases that could cause the development of this peritonitis in this patient were excluded. The purpose of the article is to point out the possibility of the development of this surgical disease, as a direct complication of the new coronavirus infection COVID-19. The article also presents the author's attempt to explain in general terms the pathogenesis of the development of peritonitis in COVID-19 in humans. Observing the second year of the pandemic, extremely rare mentions in medical scientific articles of cases of primary peritonitis in COVID-19, we can conclude that this complication is not typical in this new infection. However, given the too short period since the emergence of a new coronavirus infection COVID-19 (less than two years), as well as the ability of a new strain of coronavirus to mutate, we can assume that, in principle, the possibility of developing coronavirus peritonitis in humans is not excluded in the future.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - The Peritonitis as a Casuistic Clinical Manifestation of the New Coronavirus Disease SARS-CoV-2 COVID-19
AU  - Gorolyuk Anna Yuriyivna
Y1  - 2021/10/30
PY  - 2021
N1  - https://doi.org/10.11648/j.cmr.20211005.13
DO  - 10.11648/j.cmr.20211005.13
T2  - Clinical Medicine Research
JF  - Clinical Medicine Research
JO  - Clinical Medicine Research
SP  - 169
EP  - 172
PB  - Science Publishing Group
SN  - 2326-9057
UR  - https://doi.org/10.11648/j.cmr.20211005.13
AB  - Since the announcement of the COVID-19 pandemic (March 11, 2020), the focus of the study of complications of this new coronavirus disease has been on pneumonia and acute respiratory distress syndrome. Meanwhile, with COVID-19, acute abdominal surgical diseases develop, presumably due to the tropism of the COVID-19 virus to angiotensin-converting enzyme receptors in the digestive tract. In principle, previously known coronaviruses could cause infectious peritonitis, however, such cases of coronavirus peritonitis were observed exclusively in animals. In particular, FIPV - coronavirus is the direct cause of feline infectious peritonitis. This article describes a rare, alarming case of serous fibrinous peritonitis as a casuistic manifestation of a new coronavirus infection COVID-19 directly in humans: a 55-year-old female patient. Surgical diseases that could cause the development of this peritonitis in this patient were excluded. The purpose of the article is to point out the possibility of the development of this surgical disease, as a direct complication of the new coronavirus infection COVID-19. The article also presents the author's attempt to explain in general terms the pathogenesis of the development of peritonitis in COVID-19 in humans. Observing the second year of the pandemic, extremely rare mentions in medical scientific articles of cases of primary peritonitis in COVID-19, we can conclude that this complication is not typical in this new infection. However, given the too short period since the emergence of a new coronavirus infection COVID-19 (less than two years), as well as the ability of a new strain of coronavirus to mutate, we can assume that, in principle, the possibility of developing coronavirus peritonitis in humans is not excluded in the future.
VL  - 10
IS  - 5
ER  -

Copy | Download